Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions:  Bladder Urothelial Carcinoma;  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Prostate Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage IV Bladder Cancer;  Stage IV Prostate Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  ...
Source: ClinicalTrials.gov - July 17, 2009 Category: Research Source Type: clinical trials
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions:  Bladder Urothelial Carcinoma;  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Prostate Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage IV Bladder Cancer;  Stage IV Prostate Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  ...
Source: ClinicalTrials.gov - July 17, 2009 Category: Research Source Type: clinical trials
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions:  Bladder Urothelial Carcinoma;  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Prostate Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage IV Bladder Cancer;  Stage IV Prostate Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  ...
Source: ClinicalTrials.gov - July 17, 2009 Category: Research Source Type: clinical trials
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions:  Bladder Urothelial Carcinoma;  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Prostate Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage IV Bladder Cancer;  Stage IV Prostate Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  ...
Source: ClinicalTrials.gov - July 17, 2009 Category: Research Source Type: clinical trials
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions:  Bladder Urothelial Carcinoma;  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Prostate Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage IV Bladder Cancer;  Stage IV Prostate Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  ...
Source: ClinicalTrials.gov - July 17, 2009 Category: Research Source Type: clinical trials
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function
Conditions:  Distal Urethral Cancer;  Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;  Proximal Urethral Cancer;  Recurrent Bladder Cancer;  Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;  Recurrent Urethral Cancer;  Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;  Stage III Bladder Cancer;  Stage IV Bladder Cancer;  Transitional Cell Carcinoma of the Bladder;  Urethral Cancer Associated With Invasive Bladder CancerInterventions:  Drug: Gemcitabine hydrochloride;  Drug: Paclitaxel;  Drug: Doxorubicin hydrochlorid...
Source: ClinicalTrials.gov - May 23, 2007 Category: Research Source Type: clinical trials
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
Conditions:  Adenocarcinoma of the Bladder;  Distal Urethral Cancer;  Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;  Proximal Urethral Cancer;  Recurrent Bladder Cancer;  Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;  Recurrent Urethral Cancer;  Squamous Cell Carcinoma of the Bladder;  Stage III Bladder Cancer;  Stage III Urethral Cancer;  Stage IV Bladder Cancer;  Transitional Cell Carcinoma of the Bladder;  Urethral Cancer Associated With Invasive Bladder CancerInterventions:  Biological: ziv-aflibercept;  Other: ph...
Source: ClinicalTrials.gov - December 4, 2006 Category: Research Source Type: clinical trials
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions:  Distal Urethral Carcinoma;  Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;  Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;  Proximal Urethral Carcinoma;  Recurrent Bladder Carcinoma;  Recurrent Urethra Carcinoma;  Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;  Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;  Stage III Bladder Cancer;  Stage III Urethral Cancer;  Stage IV Bladder Cancer;  Stage IV Urethral Cancer;  Ureter CarcinomaInterventions:  Drug: Eribulin Mesylate;  Other:Â...
Source: ClinicalTrials.gov - August 16, 2006 Category: Research Source Type: clinical trials
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions:  Distal Urethral Cancer;  Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;  Proximal Urethral Cancer;  Recurrent Bladder Cancer;  Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;  Recurrent Urethral Cancer;  Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;  Stage III Bladder Cancer;  Stage III Urethral Cancer;  Stage IV Bladder Cancer;  Stage IV Urethral Cancer;  Ureter Cancer;  Urethral Cancer Associated With Invasive Bladder CancerInterventions:  Drug: eribulin mesylate;  Other: laboratory biomarkerÂ...
Source: ClinicalTrials.gov - August 16, 2006 Category: Research Source Type: clinical trials
